ОРГАНОЗБЕРІГАЛЬНІ ОПЕРАЦІЇ З ПРИВОДУ РАКУ МОЛОЧНОЇ ЗАЛОЗИ

R. V. Seniutovych, O. I. Ivashchuk, V. Yu. Bodiaka, O. H. Ushenko, L. Ya. Kushneryk, I. D. Postevka

Анотація


Представлений огляд літератури з проблем оцінки адекватності хірургічних країв за умов органозберігальних операцій з приводу раку молочної залози. Дозволені хірургічні краї шириною 1,0-2,0 мм при забарвленні поверхні препаратом. Одностайної думки щодо показань до проведення реексцизій немає.

Ключові слова


рак; молочна залоза; органозберігальні операції; хірургічні краї

Повний текст:

PDF

Посилання


Azu M, Abrahamse P, Katz SJ. What is an adequate margin for breast-conserving surgery? Surgeon Attitudes and Correlates. Ann. Surg. Oncol. 2010;17:558-563.

Blair SL, Thompson K, Rococco J. Attaining negative margins in breast conservation operations: Is there a consensus among breast surgeons? J. Am. Coll. Surg. 2009;209:608-613.

McCahill LE, Single RM, Aiello EJ. Bowles Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467-475.

Schwartz GF, Veronesi U, Clough KB. Proceedings of the consensus conference on breast conservation. Cancer. 2006;107:365-373.

Houssami N, Macaskill P, Marinovich ML. Metaanalysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast conserving surgery. Eur. J. Cancer. 2010;6:3219-3232.

Dunne C, Burke JP, Morrow M. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J. Clin. Oncol. 2009;27:1615-1620.

Morrow M, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA. 2012;307:509-510.

Wapnir IL, Dignam JJ, Fisher B. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J. Natl. Cancer Inst. 2011;103:478-488.

Atkins J, Al Mushawah F, Appleton CM. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J. Surg. Res. 2012;177:109-115.

McGhan LJ, McKeever SC, Pockaj BA. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann. Surg. Oncol. 2011;18:3096-3101.

Jeevan R, Cromwell DA, Trivella M. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:4505.

Tot T. The role of large format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases. Int. J. Breast. Cancer. 2012;2012:395-415.

Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am. J. Surg. 2002;184:383-393.

Taghian A, Mohiuddin M, Jagsi R. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann. Surg. 2005;241:629-639.

Caruso F, Ferrara M, Castiglione G. Therapeutic mammaplasties: full local control of breast cancer in one surgical stage with frozen section. Eur. J. Surg. Oncol. 2011;37:871-875.

Guidroz JA, Larrieux G, Liao J. Sampling of secondary margins decreases the need for re-excision after partial mastectomy. Surg. 2011;150:802-809.

Chakravorty A, Shrestha AK, Sanmugalingam N. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur. J. Surg. Oncol. 2012;38:395-398.

Persing S, James TA, Mace J. Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann. Surg. Oncol. 2011;18:3061-3065.

Arentz C, Baxter K, Boneti C. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann. Surg. Oncol. 2010;17(suppl 3):378-383.

Margenthaler JA, Gao F, Klimberg VS. Margin index: a new method for prediction of residual disease after breast-conserving surgery. Ann. Surg. Oncol. 2010;17:2696-2701.

Fisher B, Anderson S, Bryant J. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002;347:1233-1241.

Halasz LM, Sreedhara M, Chen YH. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int. J. Radiat. Oncol. Biol. Phys. 2012;82:581-586.

Mamounas EP, Tang G, Fisher B. Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20. J. Clin. Oncol. 2010;28:1677-1683.

Dignam JJ, Dukicv VM, Anderson SJ. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. Breast Cancer Res. Treat. 2009;116:595-602.

Del Turco MR, Ponti A, Bick U. Quality indicators in breast cancer care. Eur. J. Cancer. 2010;46:2344-2356.

Aiello Bowles EJ, Feigelson HS, Barney T. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC Cancer. 2012;12:136.

Mook J, Klein R, Kobbermann A. Volume of excision and cosmesis with routine cavity shave margins technique. Ann. Surg. Oncol. 2012;19:886-891.

Smith TJ, Landercasper J, Gundrum JD. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach. J. Surg. Oncol. 2010;102:34-38.


Пристатейна бібліографія ГОСТ


1. Azu M. What is an adequate margin for breast-conserving surgery? Surgeon Attitudes and Correlates / M. Azu, P. Abrahamse, S.J. Katz //Ann. Surg. Oncol. – 2010. – Vol. 17. – P. 558-563.

2. Blair S.L. Attaining negative margins in breast conservation operations: Is there a consensus among breast surgeons?/ S.L. Blair, K. Thompson, J. Rococco // J. Am. Coll. Surg. – 2009. – Vol. 209. – P. 608-613.

3. McCahill L.E. Variability in reexcision following breast conservation surgery / L.E. McCahill, R.M. Single, E.J. Aiello Bowles // JAMA – 2012. – Vol. 307. – P. 467-475.

4. Proceedings of the consensus conference on breast conservation / G.F. Schwartz, U. Veronesi, K.B. Clough [et al.] / Cancer. – 2006. – Vol. 107. – P. 365-373.

5. Houssami N. Metaanalysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast conserving surgery / N. Houssami, P. Macaskill, M.L. Marinovich // Eur. J. Cancer – 2010. – Vol. 6. – P. 3219-3232.

6. Dunne C. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ / C. Dunne, J.P. Burke, M. Morrow // J. Clin. Oncol. – 2009. – Vol. 27. – P. 1615-1620.

7. Morrow M. The challenge of developing quality measures for breast cancer surgery / M. Morrow, S.J. Katz // JAMA. – 2012. – Vol. 307. – P. 509-510.

8. Wapnir I.L. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS / I.L. Wapnir, J.J. Dignam, B. Fisher // J. Natl. Cancer Inst. – 2011. – Vol. 103. – P. 478-488.

9. Atkins J. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors / J. Atkins, F. Al Mushawah, C.M. Appleton // J. Surg. Res. – 2012. – Vol. 177. – P. 109-115.

10. McGhan L.J. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution / L.J. McGhan, S.C. McKeever, B.A. Pockaj // Ann. Surg. Oncol. – 2011. – Vol. 18. – P. 3096-3101.

11. Jeevan R. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics / R. Jeevan, D.A. Cromwell, M. Trivella // BMJ. – 2012. – Vol. 345. – P. 4505.

12. Tot T. The role of large format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases / T. Tot // Int. J. Breast. Cancer. – 2012. – Vol. 2012. – P. 395-415.

13. Singletary S.E. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy / S.E. Singletary // Am. J. Surg. – 2002. – Vol. 184. – P. 383-393.

14. Taghian A. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey / A. Taghian, M. Mohiuddin, R. Jagsi // Ann. Surg. – 2005. – Vol. 241. – P. 629-639.

15. Caruso F. Therapeutic mammaplasties: full local control of breast cancer in one surgical stage with frozen section / F. Caruso, M. Ferrara, G. Castiglione // Eur. J. Surg. Oncol. – 2011. – Vol. 37. – P. 871-875.

16. Guidroz J.A. Sampling of secondary margins decreases the need for re-excision after partial mastectomy / J.A. Guidroz, G. Larrieux, J. Liao // Surg. – 2011. – Vol. 150. – P. 802-809.

17. Chakravorty A. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery / A. Chakravorty, A.K. Shrestha, N. Sanmugalingam // Eur. J. Surg. Oncol. – 2012. – Vol. 38. – P. 395-398.

18. Persing S. Variability in the quality of pathology reporting of margin status following breast cancer surgery / S. Persing, T.A. James, J. Mace // Ann. Surg. Oncol. – 2011. – Vol. 18. – P. 3061-3065.

19. Arentz C. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy / C. Arentz, K. Baxter, C. Boneti // Ann. Surg. Oncol. – 2010. – Vol. 17 (suppl 3). – P. 378-383.

20. Margenthaler J.A. Margin index: a new method for prediction of residual disease after breast-conserving surgery / J.A. Margenthaler, F. Gao, V.S. Klimberg // Ann. Surg. Oncol. – 2010. – Vol. 17. – P. 2696-2701.

21. Fisher B. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer / B. Fisher, S. Anderson, J. Bryant // N. Engl. J. Med. – 2002. – Vol. 347. – P. 1233-1241.

22. Halasz L.M. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ / L.M. Halasz, M. Sreedhara, Y.H. Chen // Int. J. Radiat. Oncol. Biol. Phys. – 2012. – Vol. 82. – P. 581-586.

23. Mamounas E.P. Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20 / E.P. Mamounas, G. Tang, B. Fisher // J. Clin. Oncol. – 2010. – Vol. 28. – P. 1677-1683.

24. Dignam J.J. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer / J.J. Dignam, V.M. Dukicv, S.J. Anderson // Breast Cancer Res. Treat. – 2009. – Vol. 116. – P. 595-602.

25. Del Turco M.R. Quality indicators in breast cancer care / M.R. Del Turco, A. Ponti, U. Bick // Eur. J. Cancer. – 2010. – Vol. 46. – P. 2344-2356.

26. Aiello Bowles E.J. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database / E.J. Aiello Bowles, H.S. Feigelson, T. Barney // BMC Cancer. – 2012. – Vol. 12. – P. 136.

27. Mook J. Volume of excision and cosmesis with routine cavity shave margins technique / J. Mook, R. Klein, A. Kobbermann // Ann. Surg. Oncol. – 2012. – Vol. 19. – P. 886-891.

28. Smith T.J. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach / T.J. Smith, J. Landercasper, J.D. Gundrum // J. Surg. Oncol. – 2010. – Vol. 102. – P. 34-38.



Посилання

  • Поки немає зовнішніх посилань.


Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

ISSN 1727-0847 (Print)
ISSN 1993-5897 (On-line)